Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas.
Miyata Y, Yonamine N, Fujinuma I, Tsunenari T, Takihata Y, Hakoda H, Nakazawa A, Iwasaki T, Einama T, Togashi J, Tsujimoto H, Ueno H, Beck Y, Kishi Y.
Miyata Y, et al. Among authors: kishi y.
Ann Surg Oncol. 2023 Dec;30(13):8621-8630. doi: 10.1245/s10434-023-14219-3. Epub 2023 Sep 1.
Ann Surg Oncol. 2023.
PMID: 37658273